Tarsus Pharmaceuticals, Inc.
A biopharmaceutical company focused on developing and commercializing treatments for eye diseases. The company is developing eye drops for Demodex blepharitis and meibomian gland disease based on the drug Lotilaner, which is designed to paralyze and eradicate parasites such as mites by blocking the parasite-specific GABA-Cl channel. Delaware-based
Overview
Overview | |
|---|---|
Country | United States |
State | California |
Employees | 244 |
Founded | 2016 |
Financials | |
|---|---|
Market Capitalization | 1.11B |
Revenue | 42.56M |
Operating Income | -155.89M |
Operating Margin | -366.27% |
Net Income | -148.21M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4994 / 5373 |
Sector : Healthcare | 982 / 1144 |
Industry : Biotechnology | 526 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 2379 / 5565 |
Sector : Healthcare | 305 / 1182 |
Industry : Biotechnology | 120 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 4975 / 5436 |
Sector : Healthcare | 994 / 1164 |
Industry : Biotechnology | 543 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 3438 / 5330 |
Sector : Healthcare | 425 / 1174 |
Industry : Biotechnology | 117 / 667 |